JPRN-UMIN000002474已完成未知
Preventive effect of vit K, vit D and, risedronate on 3-dimensional trabecular microstructure in patients with IgA nephropathy on glucocorticoid treatment - The Preventive Risedronate Intervention for those Undergoing Steroid therapy with IgA nephropathy (PRIUS-IgA Study )
Osaka University Hospital Department of nephrology0 个研究点目标入组 30 人开始时间: 2009年10月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1, women who hope for future pregnancy 2, patients who already have had osteopenia or osteoporosis 3, patients with chronic kidney disease stage 3-5 4, postmenopausal women 5, patients with any prior history of glucocorticoid therapy
研究者
相似试验
已完成
不适用
Effect of risedronate combined with vitamin K2 in patients with osteoporosis due to the steroid therapyOsteoporosisJPRN-UMIN000006519Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine100
已完成
3 期
The effects of alendronate and Vitamin K on postmenopausal osteoporosispostmenopausal osteoporosisOsteoporosis.IRCT201504141479N3Vice president for research, Mashhad University of Medical Sciences50
Unknown
2 期
Effect of Vitamin K 2 on Vascular Calcification in Hemodialysis PatientsEnd Stage Renal DiseaseNCT04145492Ain Shams University60
已完成
不适用
Investigating the effect of vitamin K supplementation on markers of bone turnover and bone density in adolescents and adults with cystic fibrosisCystic fibrosisISRCTN14200211Barts and the London NHS Trust (UK)40
已完成
2 期
the effect of vitamin K supplementation on bone factors in hemodialysis patientsIRCT20221217056845N1Gorgan University of Medical Sciences72
